This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Trazimera (trastuzumab) Great Britain (GB) and Northern Ireland (NI)​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Trazimera (trastuzumab) 150mg Powder for Concentrate for Solution for Infusion - PI for GB
  • Trazimera (trastuzumab) 420mg Powder for Concentrate for Solution for Infusion - PI for GB

Northern Ireland

  • Trazimera (trastuzumab) 150mg, 420mg Powder for Concentrate for Solution for Infusion - PI for NI

Trazimera (trastuzumab) 150mg Powder for Concentrate for Solution for Infusion - PI for GB

Trazimera (trastuzumab) 420mg Powder for Concentrate for Solution for Infusion - PI for GB

Trazimera (trastuzumab) 150mg, 420mg Powder for Concentrate for Solution for Infusion - PI for NI

PP-TAS-GBR-0064 October 2024